The Effect of Granulocyte-Macrophage Colony-Stimulating Factor on Neutropenia and Mortality in Neonatal Sepsis | [Pakistan Armed Forces Medical Journal • 2023]

Author(s):

1. Syed Arsalan Hassan: Department of Pediatrics, Combined Military Hospital, Lahore/National University of Medical Sciences (NUMS) Pakistan,

2. Zeeshan Ahmed: Department of Pediatrics, Combined Military Hospital, Lahore/National University of Medical Sciences (NUMS) Pakistan,

3. Uneeba Syed: Department of Medicine, Services Hospital, Lahore Pakistan,

4. Muhammad Tariq Nadeem: Department of Pediatrics, Combined Military Hospital/National University of Medical Sciences (NUMS) Rawalpindi Pakistan,

5. Arshad Khushdil: Department of Pediatrics, Combined Military Hospital, Quetta/National University of Medical Sciences (NUMS) Pakistan

Abstract:

Objective: To evaluate the impact of adjuvant Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF) therapy in neonatal sepsis. Study Design: Quasi-experimental study. Place and Duration of Study: Combined Military Hospital, Lahore Pakistan, Mar 2019 to Mar 2020. Methodology: Thirty neonates (15 cases and 15 controls) were randomly selected for this study. The Interventional Group was given GM-CSF and standard-of-care treatment; the Control Group only received standard care. Both groups were followed for the primary outcome (i.e., discharge or death). Secondary outcomes included the effects of GM-CSF on haematological parameters of neonatal sepsis. Results: The mean gestational age of the children was 33.46±2.47 weeks. In the Interventional-Group, 56.7% of the neonates were discharged with the resolution of the sepsis. There was no significant difference concerning the secondary outcome, but the mortality was higher in the neonates among the Control-Group (p-value>0.05). Conclusion: Our study showed no difference in mortality between the Interventional and the Control Groups. The GM-CSF therapy could be used as an adjuvant therapy in neonates with neonatal sepsis to increase the total leukocyte and absolute neutrophil counts. Further studies are needed to holistically chart the clinical benefit of GM-CSF adjuvant therapy.

Page(s): 1644-1647

DOI: 10.51253/pafmj.v73i6.7456

Published: Journal: Pakistan Armed Forces Medical Journal, Volume: 73, Issue: 6, Year: 2023

Keywords:

Sepsis , neonates , Platelet count , Absolute Neutrophil Count , GMCSF , Total leukocyte count

References:

References are not available for this document.

Citations

Citations are not available for this document.

Citations

Downloads

Views